Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing

Recruiting N/A Interventional Study
Acute Leukemia Leukemia
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Health Services Research
Participants needed
75 (estimated)
Sponsor
Dana-Farber Cancer Institute · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This study aims to test the Tools for Reducing Inequity in Acute Leukemia (TRIAL) web-based application that is designed to support participants with acute leukemia by providing information and resources about leukemia and clinical trial participation.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age 18 or older * English speaking * Ability to understand and willingness to sign written informed consent * Clinical suspicion of acute leukemia * Admitted to DFCI-affiliated inpatient unit Exclusion Criteria: * Cognitive impairment rendering the individual unable to parti…
Contacts

Andrew Hantel, MD

617-582-9394

Andrew_hantel@dfci.harvard.edu

CONTACT

Erin Gallagher

857-215-2275

erin_gallagher@dfci.harvard.edu

CONTACT